Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the effect of repeated doses of the drug Lu AG06466 on the exposure of metoprolol, midazolam and bupropion

Key facts

Study ID

NCT04713254

Run by

H. Lundbeck A/S

People needed

15

Starts

2020-12-08

Expected to finish

2021-04-09

Last updated by the study team

2021-04-20

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Body mass index (BMI) of 18.5 to 30 kg/m2 (inclusive) at the Screening and Baseline Visits

You may not qualify if…

• The subject has any concurrent disorder that may affect the pharmacological target or absorption, distribution, or elimination of the investigational medicinal product.
• Other in- and exclusion criteria may apply

Where it is running

• Covance Dallas CRU — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.